Finance
Markets
No recent trading data. The last price we hold for RMD is from Jun 3 (48 days ago). This symbol may be delisted, renamed, or halted — the figures below reflect its last active session, not the current market.

RMD

stock Healthcare Medical Instruments & Supplies
ResMed
$186.46 +3.64 (+1.99%) Delayed · quoted 47d ago
Healthy 63% Steady

What the indicators say

Bearish 0 of 5 trend signals bullish
Momentum · RSI 14 Oversold
28
0oversold 30overbought 70100

RSI 28 — oversold: selling looks stretched and may be due for a bounce.

EMA 21 $201.66
Below
Near-term trend is down
SMA 50 $214.02
Below
Medium-term trend is down
SMA 200 $247.54
Below
Long-term trend is down
50 / 200-day
Death cross
50-day below the 200-day — bearish
Supertrend $200.40
Downtrend
Price is below the Supertrend band — bearish

A mechanical reading of the chart’s indicators — not investment advice.

Key statsas of Jun 3

The day open and close within the day's range
Low $184.06 High $190.80
Open
$186.46
+1.99%
Close
$186.46
+1.99%
52-week range where the price sits across its year
52w low $180.27 52w high $293.81
Current
$186.46
Prev close
$182.82
Volume 1.24× the 3-month average
0 avg 2× avg
Today
1.57M
3-mo avg
1.27M

Earningscalendar synced from Yahoo 57d ago

Most recent
Apr 3082 days ago
Next expected
Jul 30in 9 days · estimated from cadence

Recent earnings dates

  • Apr 30 82 days ago
  • Jan 29 173 days ago
  • Oct 30, 2025 264 days ago
  • Jul 31, 2025 355 days ago

Past earnings dates come from RMD’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.

Fundamentalssynced from SEC 51d ago

Strong

Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), RMD’s fundamentals read as strong overall.

P/E ratio Strong
18.0x

At 18.0x, the price is a reasonable multiple of the company's annual profit.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Fair
1.14%

A 1.1% yield is modest: a small income on top of whatever the share price does.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Strong
27.2%

A 27.2% margin is strong; the company keeps a healthy slice of every revenue dollar.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Strong
23.5%

A 23.5% return on equity is strong; the company compounds owners' capital well.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Strong
17.1%

A 17.1% return on assets is strong; the company squeezes good profit from its assets.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity Strong
0.37

At 0.37, the company carries less in liabilities than in equity, a conservative balance sheet.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Strong
3.44

At 3.44, short-term assets comfortably cover short-term bills.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Fair
+9.8%

Revenue grew 9.8% from the prior year: steady, modest expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Strong
+37.2%

Net income grew 37.2% from the prior year: strong profit expansion.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financialssynced from SEC 51d ago

FY2021FY2022FY2023FY2024FY2025
Revenue $3.2B$3.6B$4.2B$4.7B$5.1B
Net income $474.5M$779.4M$897.6M$1.0B$1.4B
Diluted EPS $3.24$5.30$6.09$6.92$9.51
Dividend / share $1.56$1.68$1.76$1.92$2.12
Total assets $4.7B$5.1B$6.8B$6.9B$8.2B
Total liabilities $1.8B$1.7B$2.6B$2.0B$2.2B
Shareholder equity $2.9B$3.4B$4.1B$4.9B$6.0B

Leadershipsynced from SEC 53d ago

  • Farrell Michael J. Chairman and CEO · Director
  • Bloomer Aaron Chief Financial Officer
  • Sandercock Brett Chief Financial Officer
  • Farrell Peter C Director

Officers and board are drawn from RMD’s recent SEC ownership filings (Forms 3, 4 and 5).

Notable recent eventspast year

Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.

Dividendssynced from Yahoo 52d ago

Pays quarterly Strong
2025 total
$2.26
2026 so far
$1.202 payments
2026 projected
$2.40+6.2% vs 2025

Projection scales RMD’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.

Payment history

  • May 14 $0.60
  • Feb 12 $0.60
  • Nov 13, 2025 $0.60
  • Aug 14, 2025 $0.60
  • May 8, 2025 $0.53
  • Feb 13, 2025 $0.53
  • Nov 7, 2024 $0.53
  • Aug 15, 2024 $0.53
  • May 8, 2024 $0.48
  • Feb 7, 2024 $0.48
  • Nov 8, 2023 $0.48
  • Aug 16, 2023 $0.48
  • May 10, 2023 $0.44
  • Feb 8, 2023 $0.44
  • Nov 9, 2022 $0.44
  • Aug 17, 2022 $0.44
  • May 11, 2022 $0.42
  • Feb 9, 2022 $0.42
  • Nov 9, 2021 $0.42
  • Aug 18, 2021 $0.42

Recent SEC filingssynced from SEC 51d ago